Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2

被引:0
|
作者
Kadoi, Kenji [1 ]
Toba, Junya [1 ]
Uehara, Ayana [1 ]
Isoda, Norikazu [2 ]
Sakoda, Yoshihiro [2 ]
Iwamoto, Eri [1 ]
机构
[1] JNC Corp, Yokohama R&D Ctr, 5-1 Ookawa,Kanazawa ku, Yokohama, Kanagawa 2368605, Japan
[2] Hokkaido Univ, Fac Vet Med, Lab Microbiol, Kita 18,Nishi 9,Kita Ku, Sapporo, Hokkaido 0600818, Japan
关键词
Monolith; SARS-CoV-2; Chromatography; Purification; pseudo-affinity; CELLUFINE SULFATE; INFLUENZA-A; VACCINE; VIRUSES; PURIFICATION;
D O I
10.1016/j.vaccine.2025.126951
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Traditional virus chromatographic purification face limitations owing to the small pore sizes of conventional resins, which restrict efficient virus binding. The newly developed MLP1000 DexS, a cellulose monolith-like particle (MLP) with large continuous pores (radius of 1.5 mu m) and a sulfate pseudo-affinity ligand, facilitates virus access to intraparticle surfaces and significantly enhances binding capacity. In this study, we investigated the effectiveness of MLP1000 DexS for purifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from Vero cells. Using a 0.29 mL column volume, we evaluated this resin through bind-elute mode chromatography under two load volume conditions (4.5 mL and 21 mL). MLP1000 DexS exhibited superior performance under high-loading conditions, achieving a high elution recovery of 59 % for the virus compared with that of 11-17 % for the commercial resins Cellufine Sulfate and Capto DeVirS. Additionally, the dsDNA removal capacity of MLP1000 DexS was 3.0-5.3-fold higher than that of the other resins. These findings suggest that MLP1000 DexS is an effective purification material for the downstream processing of live-attenuated and inactivated coronavirus vaccine production.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Efficient Selective Adsorption of SARS-CoV-2 via the Recognition of Spike Proteins Using an Affinity Spongy Monolith
    Kubo, Takuya
    Kanao, Eisuke
    Ishida, Koki
    Minami, Shohei
    Tanigawa, Tetsuya
    Mizuta, Ryosuke
    Sasaki, Yoshihiro
    Otsuka, Koji
    Kobayashi, Takeshi
    ANALYTICAL CHEMISTRY, 2023, 95 (35) : 13185 - 13190
  • [2] Strengths and limitations of SARS-CoV-2 virus-like particle systems
    Sultana, Rokaia
    Stahelin, Robert V.
    VIROLOGY, 2025, 601
  • [3] SARS-CoV-2 Neutralization Assay System using Pseudo-lentivirus
    Armimi, Anastasia
    Syuaib, Afina Firdaus
    Vanya, Katherine
    Tan, Marselina Irasonia
    Natalia, Dessy
    Chen, David Virya
    Ono, Chikako
    Matsuura, Yoshiharu
    Artarini, Anita
    Giri-Rachman, Ernawati Arifin
    INDONESIAN BIOMEDICAL JOURNAL, 2023, 15 (02): : 179 - 186
  • [4] Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins
    Kim, Seunghyeon
    Yee, Emma
    Miller, Eric A.
    Hao, Yining
    Tay, Dousabel M. Y.
    Sung, Ki-Joo
    Jia, Huan
    Johnson, Joseph M.
    Saeed, Mohsan
    Mace, Charles R.
    Yurt, Deniz Yuksel
    Sikes, Hadley D.
    ACS APPLIED MATERIALS & INTERFACES, 2021, 13 (33) : 38990 - 39002
  • [5] HexaPro spike decorated virus like particle vaccine aganist SARS-Cov-2
    Yilmaz, Ismail Cem
    Guvencli, Nese
    Yilmaz, Naz
    Ipekoglu, Emre Mert
    Turay, Nilsu
    Bulbul, Artun
    Yildirim, Muzaffer
    Evcili, Irem
    Aydin, Yagmur
    Baydemir, Ilayda
    Bildik, Kadriye Tugce
    Saraydar, Berfu
    Gursel, Ihsan
    Gursel, Mayda
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 375 - 375
  • [6] Advances in virus-like particle-based SARS-CoV-2 vaccines
    Hao, Xiaoting
    Yuan, Feifei
    Yao, Xuan
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [7] Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
    Kim, Chulwoo
    Kim, Jae-Deog
    Seo, Sang-Uk
    JOURNAL OF MICROBIOLOGY, 2022, 60 (03) : 335 - 346
  • [8] Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
    Chulwoo Kim
    Jae-Deog Kim
    Sang-Uk Seo
    Journal of Microbiology, 2022, 60 : 335 - 346
  • [9] An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
    Shiho Tanaka
    Gard Nelson
    C. Anders Olson
    Oleksandr Buzko
    Wendy Higashide
    Annie Shin
    Marcos Gonzalez
    Justin Taft
    Roosheel Patel
    Sofija Buta
    Ashley Richardson
    Dusan Bogunovic
    Patricia Spilman
    Kayvan Niazi
    Shahrooz Rabizadeh
    Patrick Soon-Shiong
    Scientific Reports, 11
  • [10] An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
    Tanaka, Shiho
    Nelson, Gard
    Olson, C. Anders
    Buzko, Oleksandr
    Higashide, Wendy
    Shin, Annie
    Gonzalez, Marcos
    Taft, Justin
    Patel, Roosheel
    Buta, Sofija
    Richardson, Ashley
    Bogunovic, Dusan
    Spilman, Patricia
    Niazi, Kayvan
    Rabizadeh, Shahrooz
    Soon-Shiong, Patrick
    SCIENTIFIC REPORTS, 2021, 11 (01)